Prostate cancer vaccine a step closer
Human clinical trials into the drug are due to start shortly, after the drug, which works to activate the immune system against prostate cancer, was successful in pre-clinical laboratory trials. The vaccine could go into clinical production, if the human trials are successful, and end up in pharmacies in seven years time.
Ireland has a higher incidence of prostate cancer than Britain – and a higher death rate. The incidence of prostate cancer here continues to grow due to an ageing male population.
